Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolid in Mycobacterium Avium Complex Pulmonary Disease
NCT07084402Phase 4Recruiting
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of contezolid in mycobacterium avium complex pulmonary disease (MAC-PD). Started Jul 2025; status: recruiting.
02
Drugs
contezolid
03
Conditions
mycobacterium avium complex pulmonary disease (MAC-PD)
Beyond the preview
Go deeper on NCT07084402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07084402.